Ohio Cancer Research Associates, OCRA, an organization dedicated to the cure and prevention of the many forms of cancer, honored Stanton L. Gerson, MD, for his contributions to cancer research at the OCRA's Singular Sensation ceremony and banquet on November 22, 2013. Dr. Gerson was recognized for his substantial impact on patients and their families, his strong community advocacy and for his work in cancer research. [more]
Researchers at Case Western Reserve University have received two grants totaling nearly $1.7 million to build nanoparticles that seek and destroy metastases too small to be detected with current technologies. They are targeting aggressive cancers that persist through traditional chemotherapy and can form new tumors. The stealthy travel and growth of micrometastases is the hallmark of metastatic disease, the cause of most cancer deaths worldwide.
The group, led by Efstathios Karathanasis, assistant professor of biomedical engineering and radiology, will spend the next five years perfecting molecular coatings, called ligands, that enable nanochains injected into a patient's blood to home in on micrometastases. The National Cancer Institute awarded the group $1.6 million to pursue the work. [more]